Puberty and Growth Flashcards

1
Q

WHO vs CDC growth curve

A

WHO
- Breastfed infants to 12m
- How kids should grow in ideal conditions
- No weight plot after age 10yrs – recommend plotting BMI only
- Addition of %iles – up to 99.9th and down to the 0.1th %iles
- International sample population (vs.US)

CDC
- Observational describe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how to measure growth proportions

A

1) U/L segment ratio
- lower segment = from the pubic symphysis to the ground while the child is standing straight with shoes off and feet
together
- upper segment= Subtract the lower segment from the total height
- Calculate ratio
**Normal is 1.7 in neonate to slightly below 1.0 in the adult.

2) Arm span
- Measure child’s arm span while she/he is standing with back touching wall and feet together. Arms should be fully extended against the wall and parallel to the floor with fingers together and outstretched, palms facing forward. Measure straight across (to length of 3rd finger), on the wall, once the child has stepped away.
**Should be ~ equal to height

3) Head circumference
- Measure from the occiput to the forehead around the head – objective is to measure maximal HC. Rpt 3x.
- Plot measurement on growth curve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Causes of abnormal proportions

A

Increased U/L
1. Achondroplasia
2. Hypochondroplasia
3. Turner
● Osteogenesis imperfecta
● Hypophosphatemic rickets
● (Pseudo)pseudohypoparathyroidism

Decreased U/L
1. Scoliosis
2. Spinal irradiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

where is GH produced/secreted

A

anterior pituitary somatotrophs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

where is the Main organ GH acts to make IGF1

A

liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

GH receptor - what does it activate and cause

A

activates post receptor signaling through JAK/STAT

Leads to transcription of 3 important GH dependent genes:
IGF-1
IGFBP-3
ALS (acid labile subunit)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Growth hormone receptor pathway steps

A
  1. Dimerization of GH receptors
    i. Different domains of a single GH molecule associate with homologous regions on 2 independent GH receptors, promoting dimerization of the receptors.
    GH receptor lack a tyrosine kinase domain
  2. Recruitment of JAK2 (Janus Kinase 2)
    i. With dimerization, JAK2 is associated with and activated by the GH receptors.
  3. Activation of JAK2’s intrinsic tyrosine kinase activity
    i. JAK2 undergoes autophosphorylation and concurrently tyrosine phosphorylates the GH receptors
  4. Recruitment of STAT (Signal Transducer & Activator of Transcription) Factors:
    i. The phosphorylation of the GH receptors by JAK2, provides a docking station for STAT factors (STAT5a & STAT5b are most relevant to GH).
  5. Transcription
    i. STATs are phosphorylated. They dissociate from the GHR, migrate to the nucleus, and bind to specific STAT-binding DNA regulatory elements (SIE/ISRE/ GAS) responsible for transcriptional control of GH target genes such as IGF-1.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pharmacologic agents that stimulate secretion of GH

A
  • AMINO ACID
    Arginine
  • NEUROTRANSMITTER
    Clonidine (alpha adrenergic agonist)
    L-dopa (dopamine agonist)
    Propranolol (beta-adrenergic antagonist)
    GABA agonists (muscimol)

ALPHA AGONIST
BETA ANTAGONIST

  • HYPOGLYCEMIA
    Glucagon (relative hypoglycemia)
    Insulin (hypoglycemia)
  • HORMONES
    GHRH
    Peptide–ACTH, alpha-MSH, vasopressin
    Estrogen
  • OTHER
    Potassium infusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Physiologic stimulants for GH

A

Hypoglycemia
Exercise
Sleep
Stress
Protein depletion/starvation/AN
Chronic renal failure
Ectopic production of GHRH
Acromegaly (TRH, GnRH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

physiologic inhibitors of GH secretion

A

Hyperglycemia (postprandial)
Elevated FFA
Obesity
Hypo or hyperthyroidism
Somatostatin
Progesterone
Glucocorticoids
Alpha adrenergic inhibition
Beta adrenergic stimulation (GH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what hormones are involved in growth

A

Growth hormone
Thyroid hormone
Sex steroids
Corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Growth hormone - other name
- stimulated by
- inhibited by

A

somatotropin

stimulated by GH-releasing hormone (GHRH or GRF)

suppressed by hypothalamic GH release-inhibiting factor (somatostatin or SRIF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what does GH do directly, besides IGF1

A

stimulates lipolysis,
increased amino acid transport into tissues,
increased protein and glucose synthesis in liver
also has direct effect on cartilage growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how is GH secreted throughout day

A

in a pulsatile manner

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Clinical Signs of GH deficiency

A
  • Poor growth
    (increased fat mass leading to a chubby or cherubic appearance with immature facial appearance, immature high-pitched voice, and delay in skeletal maturation)
    midface hypoplasia
  • Neonatal Hypoglycemia
  • Prolonged jaundice
  • Micropenis
  • breech position
  • delayed dentition
  • giant cell hepatitis
  • midline defects
  • higher incidence of hyperlipidemia with elevated total cholesterol and low-density lipoprotein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what agent can be used for a GH stim test

A

L-Dopa
Clonidine
Arginine
Glucagon
Insulin-induced hypoglycemia (very dangerous)
GHRH
Growth hormone–releasing peptides (GRP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

how do corticosteroids affect growth

A

if XS - poor growth
if low, not a big effect if well otherwise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Acquired causes of GH deficiency

A

Hypothalamic-pituitary tumors
Histiocytosis X
Central nervous system infections
Head injuries
GH deficiency following cranial irradiation
Central nervous system vascular accidents
Hydrocephalus
Empty sella syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Syndromes/Conditions w Short Stature + Obesity

A

Laurence-Moon
Biedl-Bardet
Prader-Willi syndrome
hypothyroidism,
glucocorticoid excess,
pseudohypoparathyroidism with Albright Hereditary Osteodystrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

achondroplasia
gene

features

A

FGFR3 mutation

frontal bossing
mid-face hypoplasia
exaggerated lumbar lordosis
limited elbow extension
genu varum
trident hand
motor delay
spinal stenosis
obesity

intelligence normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Russell silver syndrome

criteria for dx

A

4/6 of:

  1. SGA (birth weight and/or length ≥2 SD below the mean for gestational age)
  2. Postnatal growth failure (length/height ≥ 2 SD below the mean at 24 months)
  3. Relative macrocephaly at birth (HC >1.5 SD above birth weight and/or length)
  4. Frontal bossing or prominent forehead (forehead projecting beyond the facial plane on a side view as a toddler [1–3 years])
  5. Body asymmetry (limb length discrepancy ≥0.5 cm, or <0.5 cm with ≥2 other asymmetric body parts)
  6. Feeding difficulties or body mass index ≤2 SD at 24 months or current use of a feeding tube or cyproheptadine for appetite stimulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what does SHOX stand for

A

Short stature HOmeoboX-containing gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Noonan syndrome

A

short stature, webbed neck, low posterior hairline, and facial resemblance to Turner syndrome, but the karyotype is 46,XX in the female or 46,XY in the male

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Prader Willi Syndrome

A

poor intrauterine movement,
acromicria (small hands and feet),
developmental delay
almond-shaped eyes along
infantile hypotonia
poor feeding as infant

short stature
insatiable hunger
obesity
glucose intolerance
delayed puberty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Prader Willi syndrome gene

A

lack of expression of paternally inherited imprinted genes on chromosome 15q11-13

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

when to stop GH therapy

A

GV <2cm/y
BA fused

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

GH Tx Side Effects

A

intracranial hypertension
slipped capital femoral epiphysis (SCFE)
scoliosis progression
Insulin resistance
Theoretical increased risk of malignancy
Gynecomastia (for boys)
Local reaction at site of injection
Increased growth of nevi (?)
Hypertrophy of tonsils/adenoids (?)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Laron syndrome

A

= GH insensitivity

Molecular mechanism:
- Primary GH resistance - Receptor mutation (decreased or absent).
Note: Decreased serum GHBP levels
- GH insensitivity - Post-receptor defects.
Note: Normal GHBP levels
- Primary IGF-1 deficiency – synthesis or receptor

Autosomal recessive
GH elevated due to decreased or absent IGF-1
Does not respond to GH treatment… need recombinant IGF-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Causes of tall stature: nonendocrine

A
  • constitutional tall stature
  • genetic tall stature
  • syndromes of tall stature
    —Kilnefelter
    —Marfan
    —-Cerebral gigantism
    —Homocystinura
    —Beckwith-Wiedemann
  • XYY and XYYY syndromes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Causes of tall stature: endocrine

A

Pituitary gigantism
Sexual precocity
Thyrotoxicosis
IDM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

GH excess - names

A

pituitary gigantism before epiphyseal fusion
acromegaly after

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

pituitary gigantism - features

A

Grow excessively rapidly,
coarse features,
large hands and feet with thick fingers and toes, and
often frontal bossing and large jaws

glucose intolerance or frank diabetes mellitus,
hypogonadism, and
thyromegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

pituitary gigantism - causes

A
  1. GH secreting pituitary adenoma or somatotrophs
  2. constitutive activation of GH secretion as is sometimes found in the McCune-Albright syndrome
  3. excess secretion of GHRH

ectopic GH secretion (rare)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

thyrotoxicosis and growth

A

increased growth, advanced bone age, and, if occurring in early life, craniosynostosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

how to test for pituitary gigantism

A

GH suppression test with OGTT
1.75g/kg oral glucose (max 75g)
measure serum GH before and two hours after glucose administration
GH should be <1 or 5 ng/L depending on resource

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

effects of anorexia nervosa

A
  • GH axis: low IGF1, normal or high GH
  • insulin: low
  • cortisol: high
  • thyroid: sick euthyroid
  • hypogonadotropic hypogonadism
  • decreased leptin and oxytocin
  • increase ghrelin, peptide YY and adiponectin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Signs of estrogenization

A
  • Breast development (mainly from E, but other factors too)
  • Areolae become more pigmented and erectile as development progresses
  • Enlargement of the labia minora and majora
  • Dulling of the vaginal mucosa from its prepubertal reddish hue to pink (due to cornification of the vaginal epithelium),
  • Production of a clear or slightly whitish vaginal secretion prior to menarche
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Start of central puberty in males
- physiology

A

Starts with testicular enlargement
2.5cm or 4ml

Most of the increase in testicular size is due to seminiferous tubular development secondary to stimulation by follicle-stimulating hormone (FSH), with a smaller component due to Leydig cell stimulation by luteinizing hormone (LH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

hCG secreting tumour - what happens to male testes

A

Leydig cells are stimulated by LH (not FSH) so the testis does not grow as large as in normal puberty. (but they do enlarge)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

mechanism of earlier puberty in obese females

A

local aromatase activity in adipose tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

how does estrogen affect growth

A
  • indirectly stimulates IGF-I production by increasing the secretion of GH
  • directly stimulates IGF-I production in cartilage
  • stimulating maturation of the chondrocytes and osteoblasts, ultimately leading to epiphysial fusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

when do boys and girls reach peak mineralization of bone

A

Girls reach peak mineralization between 14 and 16 years of age, whereas boys reach a later peak at 17.5 years

43
Q

female athletic triad

A

exercise-induced amenorrhea,
premature osteoporosis, and
disordered eating

44
Q

sex hormone binding protein - factors that increase and decrease

A

Factors that increase
Estrogen (& Tamoxifen) / Pregnancy
Thyroid hormone administration & hyperthyroidism
Phenytoin
Cirrhosis
HIV?

Factors that decrease
Hypothyroidism
Nephrotic syndrome
GH administration / Acromegaly
Obesity & hyperinsulinemic states
Exogenous androgens
Glucocorticoids

45
Q

during fetal life, what hormones are produced by the male and female gonads

A

Males:
- LH stimulates the Leydig cells to secrete testosterone, and
- FSH stimulates the Sertoli cells to produce inhibin. Inhibin feeds back on the hypothalamic-pituitary axis to inhibit FSH

Females:
- FSH stimulates the granulosa cells to produce estrogen and the follicles to secrete inhibin

46
Q

what is another important hormone for pubertal development

A

Leptin is a necessary component of pubertal development in human beings but not a major stimulant to this development; leptin is necessary but not sufficient for pubertal development.

47
Q

what hormones play roles of importance in the onset of puberty?

A

kisspeptin (KISS1)
GRP54 (kisspepin receptor, G protein–coupled receptor 54)

MKRN3 (precocious puberty)
DLK1 (precocious puberty)

LEP
LEPR
TAC3
TAC3 receptor

48
Q

when do the adrenal glands start secreting androgens

A

The adrenal cortex normally secretes the weak androgens dehydroepiandrosterone (DHEA), its sulfate, dehydroepiandrosterone sulfate (DHEAS), and androstenedione in increasing amounts beginning at about 6 to 7 years of age in girls and 7 to 8 years of age in boys

49
Q

what are metabolic changes during puberty

A

boys:
hematocrit rises
high-density lipoprotein (HDL) concentrations fall

both boys and girls
alkaline phosphatase rises normally during the pubertal growth spurt
Serum IGF-I concentrations rise with the pubertal growth spurt, but IGF-I is more closely correlated with sex steroid concentration than with growth rate

50
Q

when do IGF1 levels peak

A

1 year after peak growth velocity is reached and remain elevated for 4 years thereafter, even though growth rate is decreasing

51
Q

classification of causes of delayed puberty

A

Constitutional delay in growth and adolescence
Hypogonadotropic hypogonadism
Hypergonadotropic hypogonadism

52
Q

Causes of central delayed puberty

A

Constitutional delay in growth and adolescence

Central nervous system disorders
- Congenital disorders of the hypothalamus or pituitary
- Tumors
- Other acquired disorders
- Infection
- Trauma
- Irradiation

Defects of the hypothalamic-pituitary axis
- Isolated gonadotropin deficiency
—Kallmann syndrome
—Gonadotropin deficiency with normal sense of smell (Idiopathic Hypogonadotropic Hypogonadism)
- Multiple pituitary hormonal deficiencies
- Miscellaneous disorders
—Syndromes
—Chronic disease
—Weight loss
—Anorexia nervosa
—Increased physical activity in female athletes
—Hypothyroidism

Genetic syndromes
- Prader-Willi syndrome
- Bardet-Biedl syndrome

53
Q

Causes of Hypergonadotropic hypogonadism

A

Male phenotype
- Klinefelter syndrome (gonadal dysgenesis)
- Other forms of primary testicular failure (including chemotherapy, autoimmune, radiation, trauma)
- Enzymatic defects of androgen production
- Anorchia or cryptorchism

Female phenotype
- Turner syndrome(gonadal dysgenesis)
- Other forms of primary ovarian failure (including chemotherapy)

Pseudo–Turner syndrome

Noonan syndrome

XX and XY gonadal dysgenesis

54
Q

Klinefelter (47,XXY karyotype)

A

Hypergonadotropic Hypogonadism
primary testicular failure – seminiferous tubule dysgenesis

decreased upper segment-lower segment ratios
small testes
developmental delay
personality disorder

55
Q

what happens in Klinefelter syndrome to testes

A

Onset of puberty is not usually delayed, because Leydig cell function is characteristically less affected than seminiferous tubule function in this condition and testosterone is adequate to stimulate pubertal development.

Serum gonadotropin levels rise to castrate concentrations after the onset of puberty; the testes become firm and are rarely larger than 3.5 cm in diameter

After the onset of puberty, there are histologic changes of seminiferous tubule hyalinization and fibrosis, adenomatous changes of the Leydig cells, and impaired spermatogenesis

56
Q

Vanishing Testes Syndrome

A

46,XY
otherwise normal a
late fetal loss of the testes
normal infantile male genital development, including Wolffian duct formation and Müllerian duct regression.

The testes were presumably present in these patients early in fetal life during sexual differentiation, but degenerated after the 13th week of gestation for unknown reasons

57
Q

isosexual precocity vs contrasexual precocity

A

isosexual precocity: feminization in girls and virilization in boys

contrasexual precocity: feminization in boys and virilization in girls

58
Q

Causes of Central precocious puberty

A
  • Constitutional
  • Idiopathic
  • Central nervous system disorders (including congenital defects)
    —Tumors (Hypothalamic hamartoma, astrocytoma, glioma)
    —Infection
    —Trauma
    —Radiation
    —CNS disorders (static encephalopathy, low dose cranial irradiation, hydrocephalus)
    —Following androgen exposure
    -Profound hypothyroidism
59
Q

Causes of Peripheral precocious puberty

A

Males
Gonadotropin-secreting tumors
Excessive androgen production
Testicular or adrenal tumors
Virilizing congenital adrenal hyperplasia
Premature Leydig and germinal cell maturation
hCG secreting tumours

Females
Ovarian follicular cysts
Estrogen-secreting neoplasms
Severe hypothyroidism
Granulosa cell tumour

Males and females
McCune-Albright syndrome

Exogenous exposure

60
Q

treatment for PCOS

A

Lifestyle – weight loss is 1st line therapy in overweight/obese subjects

OCPs:
Raise SHBG -> decrease testosterone effects;
may decrease ovarian hyperandrogenism;
induces regular menses

Metformin:
induces regular menses;
short term improvement of metabolic derangements in obese subjects

Anti-Androgen:
spironolactone – as adjuvant with OCPs and metformin

61
Q

What is def of ISS

A

○ height standard deviation score (SDS) ≤ –2.25 (PES)

○ unlikely to permit attainment of adult height in the expected range

62
Q

indications for GH treatment

A

GH deficiency
Turner syndrome
ISS
SGA with no catch up growth by age 3 yo
SHOX haploinsufficiency
CKD
Prader-Willi

63
Q

factors that alter IGF1

A

● GH deficiency
● GH resistance
● Malnutrition
● Hepatic failure
● Age (low in newborns, increases throughout childhood, peaks during puberty)
● Pubertal status
● Chronic disease and infections
● Pregnancy
● Thyroid function

64
Q

syndromes associated with SHOX deficiency

A

i) Leri-Weill dyschondrosteosis (heterozygous defect)
ii) Langer mesomelic dysplasia (homozygous defect)
iii) Turner Syndrome

65
Q

features associated with SHOX deficiency

A

i) Mesomelia - shorter forearms and lower legs (with reductions in arm span and leg length compared with trunk)
ii) Madelung deformity of the forearm (focal dysplasia of the distal radial physis)
iii) Short 4th or 5th metacarpal or metatarsal
iv) cubitus valgus (increased carrying angle of the arm)
v) high-arched palate
vi) scoliosis
vii) micrognathia
viii) muscular hypertrophy (reflected as a short, stocky appearance)

66
Q

when can you dx GHD without stim

A

1) Patients has all 3 of the following: auxological criteria, hypothalamic-pituitary defect, and deficiency of at least one additional pituitary hormone
2) Newborn with hypoglycemia who does not attain a serum GH concentration above 5 μg/L and has deficiency of at least one additional pituitary hormone and/ or the classical imaging triad (ectopic posterior pituitary and pituitary hypoplasia with abnormal stalk)

67
Q

starting dose of GH

A

○ Starting dose should be 0.16-0.24 mg/kg/week

68
Q

what to monitor during GH treatment

A

IGF-1 should be maintained in normal range throughout growth hormone therapy

growth

69
Q

if retesting for GHD as an adult, how long do you have to wait to be off GH?

A

1 month

70
Q

what growth velocity change is consistent with GH deficiency

A
  • Height velocity below -2SD over 1 year
  • Height velocity more than 1.5SD below mean sustained over 2 years
71
Q

side effects of clonidine

A

● Hypotension
● Drowsiness
● Dizziness
● Dry eyes or mouth
● Blurry vision

72
Q

side effects of arginine

A

● flushing
● nausea and vomiting
● hypoglycemia

73
Q

what is the expected growth of someone w ISS taking GH

A

For those with ISS they can expect a 5 cm height gain over 5 years of treatment

74
Q

Dasatinib

A

tyrosine kinase inhibitor

needed for life in CML patients

This can sometimes affect growth hormone tyrosine kinase receptor and IGF-1 signalling pathway as well as chondrocyte action at the growth plate. Due to this many patients have short stature, although most have catch up growth once they hit puberty.

75
Q

how does arginine affect GH

A

Arginine inhibits somatostatin

76
Q

how do alpha adrenergic affect GH

A

Alpha adrenergic agonists (clonidine), dopamine (levodopa), and exercise cause release of GHRH

77
Q

short and relative macrocephaly? think

A

Russell Silver syndrome

78
Q

if someone starts GH treatment for GHD then has hypoglycemia, what is going on and what is the mechanism

A

Adrenal insufficiency

Inhibition of 11β-hydroxysteroid dehydrogenase 1
- 11B HSD1 catalyzes cortisone → cortisol in adipose tissue and liver and 11B HSD2 cortisol → cortisone in kidney. Evidence that GH indirectly (through IGF-1) modulates cortisol metabolism by decreasing 11B HSD1 activity (ie you have less cortisone → cortisol conversion), which if there is some semblance of decreased cortisol production, can lead to AI once you give GH

79
Q

how does malnutrition affect growth

A

Malnutrition usually causes a drop in IGF-1. This occurs by decreasing availability of the GH receptor on the liver. Therefore malnourished patients do not respond to GH.

80
Q

primary amenorrhea defintion

A

no period by age 16 yo

81
Q

secondary amenorrhea definition

A

no menses for more than 3 cycles or more in someone who previously had cyclic menses

82
Q

secondary amenorrhea causes

A

tumour(cranio)
1. Pituitary adenoma
2. Kallmann syndrome
3. Malnutrition
4. Anorexia/extreme weight loss
5. Sheehan syndrome
6. Trauma
7. TB
8. Meningitis/Encephalitis
9. History of radiation
10. LCH
11. Sarcoidosis

83
Q

defects in estrogen biosynthesis

A

● 17,20-lyase deficiency
● CYP17a deficiency
● StAR mutation

84
Q

pubertal gynecomastia pathophys

A

A transient increase in the estradiol to testosterone ratio

85
Q

concerning features on exam for a male with gynecomastia

A

i) Tall stature (and/or developmental delay)
ii) Stigmata of liver disease (spider angiomas, jaundice, scleral icterus, etc)
iii) Abdominal mass
iv) Testicular mass
v) Gynecomastia greater than 4 cm in size
vi) Undervirilized male genitalia
vii) Small firm testes
■ Early accelerated linear growth (aromatase excess)
■ Signs of renal disease

86
Q

concerning features on history for a male with gynecomastia

A

i) Galactorrhea (more likely prolactinoma, etc)
ii) Readily increasing gynecomastia
iii) Lack of pubertal progression
iv) Exogenous estrogen exposure
v) History of testicular trauma/injury or pituitary trauma or injury
vi) Symptoms of other pituitary deficiencies
vii) History of cryptorchidism
viii) Duration longer than 2 years
ix) Breast cancer findings

87
Q

Endocrinopathies with McCune Albright

A

Cushing syndrome,
hyperthyroidism,
growth hormone excess,
hyperpararthyroidism

88
Q

what are estrogen secreting tumours

A

ovarian, Sertoli cell, adrenal tumours

89
Q

gonadal dysgenesis
- presentation
- labs
- karyotype

A

some estrogen effects (breast devel)
amenorrhea

○ Elevated FSH/LH
○ Low estradiol

○ Deletion of Xp only or iso-Xq (deletion of Xp causing fusion of 2 Xqs)

90
Q

what happens to AMH during puberty

A

low

91
Q

pituitary causes of secondary amenorrhea (6)

A

○ Pituitary tumor
○ Hyperprolactinemia
○ Surgery or radiation
○ Autoimmune
○ Infections
○ Hypotensive event (Sheehan syndrome)

92
Q

Ddx for primary amenorrhea with breast development

A

○ Functional hypogonadotropic hypogonadism (low weight, low estradiol)
○ Turner syndrome (Webbed neck, high FSH)
○ Noonan’s (murmur, low LH on stim)
○ Prader Willi or Bardet Beidl (obesity, low LH on stim)
○ XX and XY gonadal dysgenesis (virilized genitalia, Y chromosome material on FISH)
○ Primary gonadal failure (post-radiation, etc) (normal external genitalia/vaginal atrophy/lack of pubertal development, high FSH)
○ CHH (incomplete or no breast development, LH low on stim)
○ Multiple pituitary hormone deficiencies (midline defect, low LH on stimulation testing)
○ Intact hymen (hematocolpos, normal estradiol)
○ Complete AIS (no virilizing features, Y chromosome on karyotype)
○ PCOS (androgenizing features, elevated testosterone)
○ NCCAH (androgenizing features, elevated 17-OHP)

93
Q

2 meds to treat gynecomastia

A

aromatase inhibitor (anastrazole)
selective estrogen receptor blocker (tamoxifen)

94
Q

meds that cause gynecomastia

A

■ Drugs
Marijuana use
Spironolactone
Estrogen
■ Hyperprolactinemia
■ Hypogonadism
■ Hyperthyroidism
■ AIS (partial)
■ Excessive aromatase activity
■ Liver disease
■ Uremia
■ Testicular germ cell or Leydig cell tumors
■ Feminizing adrenocortical adenoma or carcinoma
■ hCG-secreting nontrophoblastic neoplasm

95
Q

med associated w gynecomastia

A

○ Spironolactone
○ Cimetidine
○ Ketoconazole
○ Estrogens
○ Anti-androgens
○ Growth hormone
○ GnRH analogue
○ 5 alpha reductase inhibitors
○ Marijuana
○ TCA
○ Ethanol
○ Heroin
○ Amphetamines
○ Anabolic steroids

96
Q

what raises and lowers SHBP

A

factors that increase SHBG
-Drugs: tamoxifen/anti-epileptic drugs
-Untreated hyperthyroidism
-Estrogen
-Pregnancy

factors that decrease SHBG
-Exogenous androgens
-Glucocorticoid therapy
-GH treatment
-Untreated hypothyroidism
-Obesity
-Hyperinsulinemic states

97
Q

how does T work at receptor

A
  1. T or DHT binds to androgen receptor
  2. Androgen/androgen receptor complex dissociates from Heat Shock Proteins and chaperone proteins, leading to a conformational change
  3. Conformational change leads to formation of a homodimer with another androgen/androgen receptor molecule
  4. Homodimer translocated to nucleus via binding to transport proteins, importins
  5. Now in the nucleus, androgen/androgen receptor molecule binds to androgen response elements in DNA and interacts with protein coactivators
  6. Initiates transcriptional activity
98
Q

initial effects of GnRH agonist

A

■ Withdrawal bleed
■ Catch down growth (GV decreases within 5 months after the start of therapy)

99
Q

side effects of GnRH agonist

A

■ Sterile abscesses
■ Decrease BMD

100
Q

GnRH stim - what if LH or FSH predominates

A

a) LH predominance
-pubertal (central puberty) that you should treat
b) FSH predominance
-slow/intermittently progressing central precocious puberty

101
Q

how does cranial irradiation affect puberty?

A

At medium dose cranial radiation there is a chance of developing precocious puberty (central), however at a high dose individuals can develop LH and FSH deficiencies

102
Q

in premature ovarian failure, what is the most common etiology

A

Ovarian failure due to follicle depletion

103
Q

how to assess fertility in females

A

AMH is representative of ovarian reserve.

However inhibin B is present during the follicular phase if there is a dominant follicle.

Therefore AMH s reflective of future fertility, but inhibin B and FSH are representative of current fertility ability.